Literature DB >> 11158138

Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics.

L P Jetté1, G Delage, L Ringuette, R Allard, P De Wals , F Lamothe, V Loo.   

Abstract

In the province of Quebec, Canada, from 1996 to 1998, 3,650 invasive Streptococcus pneumoniae infections were reported. A total of 1,354 isolates were serotyped and tested for antimicrobial susceptibility. The distribution of serotypes remained stable over the 3 years, with serotypes 14, 6B, 4, 9V, 23F, and 19F accounting for 61% of the isolates. Overall, 90% of isolates were included in the current 23-valent vaccine and 67% were included in the 7-valent conjugate vaccine. We were able to determine that resistance to penicillin and to other antibiotics is increasing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158138      PMCID: PMC87807          DOI: 10.1128/JCM.39.2.733-737.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Penicillin resistance among invasive pneumococcal isolates at 10 children's hospitals, 1991-1994. The LCDC/CPS Impact Group. The Immunization Monitoring Program, Active.

Authors:  D Scheifele; R Gold; V Marchessault; J Talbot
Journal:  Can Commun Dis Rep       Date:  1996-10-01

2.  Injuries and deaths associated with use of snowmobiles--Maine, 1991-1996.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-01-10       Impact factor: 17.586

3.  Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995.

Authors:  M Lovgren; J S Spika; J A Talbot
Journal:  CMAJ       Date:  1998-02-10       Impact factor: 8.262

4.  The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System.

Authors:  J C Butler; J Hofmann; M S Cetron; J A Elliott; R R Facklam; R F Breiman
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

5.  Pneumococcal resistance to antimicrobial agents in the province of Québec, Canada.

Authors:  L P Jetté; L Ringuette; A Dascal; J R Lapointe; P Turgeon
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

Review 6.  Pneumococcal disease: prospects for a new generation of vaccines.

Authors:  G R Siber
Journal:  Science       Date:  1994-09-02       Impact factor: 47.728

7.  Three-year multicenter surveillance of systemic pneumococcal infections in children.

Authors:  S L Kaplan; E O Mason; W J Barson; E R Wald; M Arditi; T Q Tan; G E Schutze; J S Bradley; L B Givner; K S Kim; R Yogev
Journal:  Pediatrics       Date:  1998-09       Impact factor: 7.124

8.  Introduction and clonal spread of penicillin- and trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae, serotype 9V, in southern Sweden.

Authors:  E Melander; K Ekdahl; H B Hansson; C Kamme; M Laurell; P Nilsson; K Persson; M Söderström; S Mölstad
Journal:  Microb Drug Resist       Date:  1998       Impact factor: 3.431

9.  Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

Authors:  M B Rennels; K M Edwards; H L Keyserling; K S Reisinger; D A Hogerman; D V Madore; I Chang; P R Paradiso; F J Malinoski; A Kimura
Journal:  Pediatrics       Date:  1998-04       Impact factor: 7.124

10.  Invasive Streptococcus pneumoniae infection in Latin American children: results of the Pan American Health Organization Surveillance Study.

Authors:  D A Kertesz; J L Di Fabio; M C de Cunto Brandileone; E Castañeda; G Echániz-Aviles; I Heitmann; A Homma; M Hortal; M Lovgren; R O Ruvinsky; J A Talbot; J Weekes; J S Spika
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

View more
  10 in total

1.  Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam.

Authors:  D Bogaert; N T Ha; M Sluijter; N Lemmens; R De Groot; P W M Hermans
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.

Authors:  Angela B Brueggemann; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

3.  Routine adult immunization in Canada: recommendations and performance.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis       Date:  2002-07

4.  Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release.

Authors:  James A Karlowsky; Laurie J Kelly; Ian A Critchley; Mark E Jones; Clyde Thornsberry; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Emergence of penicillin-nonsusceptible Streptococcus pneumoniae invasive clones in Canada.

Authors:  D Greenberg; D P Speert; E Mahenthiralingam; D A Henry; M E Campbell; D W Scheifele
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

6.  Comparison of methods of temperature measurement in swine.

Authors:  S K Hanneman; J T Jesurum-Urbaitis; D R Bickel
Journal:  Lab Anim       Date:  2004-07       Impact factor: 2.471

7.  Pneumococcal conjugate vaccination in Canadian infants and children younger than five years of age: Recommendations and expected benefits.

Authors:  Carol A McClure; Michael W Ford; Jeff B Wilson; Jeff J Aramini
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-01       Impact factor: 2.471

8.  Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.

Authors:  Stephanie R Earnshaw; Cheryl L McDade; Giovanni Zanotti; Raymond A Farkouh; David Strutton
Journal:  BMC Infect Dis       Date:  2012-04-24       Impact factor: 3.090

9.  Seasonal patterns of invasive pneumococcal disease.

Authors:  Scott F Dowell; Cynthia G Whitney; Carolyn Wright; Charles E Rose; Anne Schuchat
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

10.  Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada.

Authors:  Michele Wilson; Matt Wasserman; Taj Jadavi; Maarten Postma; Marie-Claude Breton; Francois Peloquin; Stephanie Earnshaw; Cheryl McDade; Heather Sings; Raymond Farkouh
Journal:  Infect Dis Ther       Date:  2018-06-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.